218 related articles for article (PubMed ID: 10673682)
1. Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy.
Hwang WY; Goh YT; Tan CH; How GF; Tan HC
Bone Marrow Transplant; 2000 Jan; 25(2):205-7. PubMed ID: 10673682
[TBL] [Abstract][Full Text] [Related]
2. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
[TBL] [Abstract][Full Text] [Related]
4. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
[TBL] [Abstract][Full Text] [Related]
5. Progressive autologous graft-versus-host disease induced by cyclosporin A.
Barredo JC; Yusuf U; Hahn A; Abboud MR; Laver J
Bone Marrow Transplant; 1996 Sep; 18(3):659-62. PubMed ID: 8879637
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
[TBL] [Abstract][Full Text] [Related]
7. Syngeneic graft-versus-host disease: a report of two cases and literature review.
Latif T; Pohlman B; Kalaycio M; Sobecks R; Hsi ED; Andresen S; Bolwell BJ
Bone Marrow Transplant; 2003 Sep; 32(5):535-9. PubMed ID: 12942102
[TBL] [Abstract][Full Text] [Related]
8. Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation.
Sato M; Matsushima T; Takada S; Hatsumi N; Kim K; Sakuraya M; Saito T; Tamura J; Karasawa M; Murakami H; Naruse T
Bone Marrow Transplant; 1998 Dec; 22(12):1219-22. PubMed ID: 9894728
[TBL] [Abstract][Full Text] [Related]
9. Rapid tapering of cyclosporin to maximise the graft-versus-leukaemia effect.
Shaw PJ; Afify Z
Bone Marrow Transplant; 1999 Mar; 23(6):632-3. PubMed ID: 10217198
[No Abstract] [Full Text] [Related]
10. Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal.
Oliveira JS; Bahia D; Franco M; Balda C; Stella S; Kerbauy J
Bone Marrow Transplant; 1999 Jan; 23(1):99-101. PubMed ID: 10037059
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
[TBL] [Abstract][Full Text] [Related]
12. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
[TBL] [Abstract][Full Text] [Related]
14. Acute graft-versus-host disease in thalassaemic marrow transplantation with low-dose antithymocyte globulin.
Khojasteh HN; Zakerinia M; Ramzi M; Haghshenas M
East Mediterr Health J; 1999 May; 5(3):465-9. PubMed ID: 10793825
[TBL] [Abstract][Full Text] [Related]
15. Atypical acute graft-versus-host disease.
Shin J; Hong W; Song H; Choi G; Kim YC
Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
[TBL] [Abstract][Full Text] [Related]
17. Isolated testicular and bone relapse in children with acute myeloblastic leukemia and chronic graft versus host disease after allogeneic BMT.
Yildirim I; Uçkan D; Cetin M; Tuncer M; Tezcan I
Turk J Pediatr; 2007; 49(2):206-9. PubMed ID: 17907524
[TBL] [Abstract][Full Text] [Related]
18. The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia.
Teuffel O; Schrauder A; Sykora KW; Zimmermann M; Reiter A; Welte K; Schrappe M
Bone Marrow Transplant; 2005 Jul; 36(2):145-50. PubMed ID: 15908976
[TBL] [Abstract][Full Text] [Related]
19. Esophageal graft versus host disease.
Sodhi SS; Srinivasan R; Thomas RM
Gastrointest Endosc; 2000 Aug; 52(2):235. PubMed ID: 10922099
[No Abstract] [Full Text] [Related]
20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
